Amir Nashat
CIK 1575843 · last filed 2026-06-12
Amir Nashat is a corporate insider who has filed 82 SEC Form 4 insider transactions across 10 companies since 2013. The most recent filing, for CAMP, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$16.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $96.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$96.54M
10
82
-$16.51M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAMP | Director | 197,661 | $4.65 | $919.1K | $12.00M | 4 | 2026-06-12 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 130,298 | $56.99 | $7.43M | -$8.69M | 9 | 2024-06-05 |
| SRRK | Director | 1,689,555 | $56.51 | $95.48M | $7.87M | 13 | 2024-05-13 |
| Metacrine, Inc. (MTCR) Delisted | Director | 2,499,210 | $0.49 | $1.24M | $2.99M | 3 | 2022-09-06 |
| Syros Pharmaceuticals, Inc. (SYRS) Delisted | Director | 2,217 | $0.00 | $1 | $5.00M | 9 | 2022-06-02 |
| FATE | Director | 11,333 | $2.65 | $30.0K | -$17.96M | 21 | 2019-08-02 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 52,156 | $0.88 | $46.0K | -$1.92M | 8 | 2019-06-18 |
| LIFE | Director | 3,354 | $32.85 | $110.2K | $0 | 6 | 2018-05-17 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 1 | 2015-06-10 |
| Receptos, Inc. (RCPT) Delisted | Director | 46,923 | — | — | -$15.80M | 7 | 2013-12-10 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | CAMP | Grant (A) | — | $0 | EDGAR |
| 2025-09-11 | CAMP | Buy (P) | +1,307,189 | $2.00M | EDGAR |
| 2025-06-27 | CAMP | Grant (A) | — | $0 | EDGAR |
| 2024-10-15 | CAMP | Mixed | +2,625,062 | $10.00M | EDGAR |
| 2024-08-20 | — | Mixed | −1,990,796 | $0 | |
| 2024-06-05 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-13 | SRRK | Other (J) | −486,545 | $0 | EDGAR |
| 2023-12-29 | SRRK | Gift (G) | −21,333 | $0 | EDGAR |
| 2023-12-15 | SRRK | Other (J) | −973,092 | $0 | EDGAR |
| 2023-11-22 | SRRK | Other (J) | −486,545 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.